This article is more than 5 years old. Information may no longer be current.

Iridex announces expansion of retinal portfolio

Issue: November 25, 2014

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — Iridex will showcase an expansion of its patented Adjustable and Intuitive Extended-Reach laser probes here at the American Academy of Ophthalmology meeting, according to company press release.

The Adjustable and Intuitive Extended-Reach (A&I XR) probes are used for laser photocoagulation during vitreoretinal procedures. The probes feature both straight and angled configurations, and are offered in 20-, 23- and 25-gauge sizes with the option of finger or thumb actuators, according to the release. 

“Our new devices further enhance our robust line of premium laser probes and amplifies our efforts to quickly design and launch consumable products to further grow our procedural-based recurring revenues,” Will Moore, Iridex president and CEO, said in the release.